Percutaneous Vessel Closure Device Market Trends and Forecast
The future of the global percutaneous vessel closure device market looks promising with opportunities in the hospital, ASC, and online markets. The global percutaneous vessel closure device market is expected to grow with a CAGR of 6.8% from 2025 to 2031. The major drivers for this market are the increasing demand for minimally invasive procedures, the rising prevalence of cardiovascular diseases, and the growing adoption in interventional cardiology.
• Lucintel forecasts that, within the type category, suture-based closure device is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the Percutaneous Vessel Closure Device Market
The percutaneous vessel closure device market is experiencing rapid growth driven by technological advancements, increasing minimally invasive procedures, and a rising prevalence of cardiovascular diseases. As healthcare providers seek safer, more efficient methods to manage vascular access sites, innovative closure devices are becoming essential. The market is also influenced by regulatory approvals, expanding applications, and the need for cost-effective solutions. These developments are transforming the landscape, making procedures safer and more accessible. Understanding the key emerging trends is crucial for stakeholders aiming to capitalize on this evolving market and improve patient outcomes through advanced closure technologies.
• Technological Innovation: The market is witnessing significant advancements in device design and materials, such as bio-absorbable and hybrid closure systems. These innovations aim to enhance safety, reduce complications, and improve ease of use. Newer devices incorporate features like rapid hemostasis and minimal vessel trauma, which are highly valued by clinicians. The integration of imaging guidance and automation further improves precision. As technology evolves, the market is expected to see increased adoption of these sophisticated devices, leading to better patient outcomes and reduced procedure times.
• Growing Adoption of Minimally Invasive Procedures: The shift towards minimally invasive surgeries, including percutaneous interventions, is a major driver. These procedures require reliable closure devices to ensure quick recovery and reduce complications. As hospitals and clinics adopt less invasive techniques for cardiac, vascular, and other interventions, demand for advanced closure devices rises. This trend is supported by patient preferences for shorter hospital stays and faster recovery times, prompting healthcare providers to prefer devices that facilitate these outcomes, thereby expanding the market.
• Rising Prevalence of Cardiovascular Diseases: The increasing incidence of conditions like coronary artery disease, peripheral artery disease, and hypertension is fueling demand for vascular access procedures. As more patients undergo interventions requiring vascular access, the need for effective closure devices grows. This trend is particularly prominent in aging populations and regions with rising lifestyle-related health issues. The market benefits from this increased demand, with manufacturers focusing on developing devices suitable for diverse patient profiles and complex procedures.
• Regulatory Approvals and Reimbursement Policies: Enhanced regulatory frameworks and favorable reimbursement policies are facilitating market growth. Approval of new devices by agencies like the FDA and EMA ensures safety and efficacy, boosting clinician confidence. Additionally, reimbursement policies that cover advanced closure devices encourage hospitals to adopt newer technologies. These regulatory and financial incentives are crucial for market expansion, especially in emerging economies, and are driving innovation and competition among manufacturers to meet stringent standards.
• Expansion of Application Areas: The use of vessel closure devices is expanding beyond traditional cardiac and vascular procedures to include interventions in neurology, oncology, and peripheral surgeries. This diversification is driven by the need for reliable, versatile closure solutions across various specialties. As new clinical applications emerge, the market is witnessing increased product development tailored to specific procedural requirements. This expansion broadens the market scope, attracting new players and fostering innovation to meet diverse clinical needs.
In summary, these emerging trends are collectively reshaping the percutaneous vessel closure device market by fostering innovation, expanding application areas, and improving procedural safety and efficiency. As these developments continue, the market is poised for sustained growth, offering improved outcomes for patients and new opportunities for manufacturers and healthcare providers alike.
Recent Development in the Percutaneous Vessel Closure Device Market
The percutaneous vessel closure device market has experienced significant advancements driven by technological innovations, increasing minimally invasive procedures, and rising demand for faster patient recovery. These developments are transforming the healthcare landscape by improving procedural safety, reducing complications, and expanding application areas. As healthcare providers seek efficient solutions, the market is poised for substantial growth, attracting investments and fostering new product launches. The following key developments highlight the current trajectory and future potential of this dynamic industry.
• Technological Innovations in Closure Devices: Enhanced safety and efficiency are achieved through advanced materials and design improvements, reducing complication rates and increasing adoption in complex procedures. These innovations enable faster hemostasis, minimize vessel trauma, and improve patient outcomes, thereby expanding the market scope. Manufacturers are investing heavily in R&D to develop next-generation devices, which are expected to set new standards in procedural safety and efficacy, ultimately driving market growth.
• Rising Adoption of Minimally Invasive Procedures: The shift towards minimally invasive techniques in cardiovascular and peripheral interventions is fueling demand for percutaneous closure devices. These procedures offer benefits such as reduced hospital stays, lower infection risks, and quicker recovery times. As healthcare systems worldwide emphasize outpatient and same-day surgeries, the adoption rate of these devices is increasing, significantly contributing to market expansion and encouraging innovation in device design.
• Increasing Prevalence of Cardiovascular Diseases: The global rise in cardiovascular conditions, including coronary artery disease and peripheral artery disease, is directly boosting the need for effective vascular closure solutions. As the patient population grows, so does the demand for reliable closure devices to facilitate complex interventions. This trend is expected to sustain market growth, prompting manufacturers to develop specialized devices tailored to diverse clinical needs and expanding the market reach.
• Growing Focus on Patient Safety and Outcomes: Emphasis on reducing procedural complications and enhancing patient safety is driving the development of smarter, more reliable closure devices. Features such as bioresorbable materials and real-time imaging compatibility are improving clinical outcomes. This focus is influencing product development strategies, leading to higher adoption rates and market confidence, ultimately fostering a safer, more effective industry landscape.
• Strategic Collaborations and Market Expansion: Key players are engaging in partnerships, acquisitions, and regional expansion to strengthen their market presence. These strategies facilitate access to emerging markets, diversify product portfolios, and accelerate innovation. As companies focus on expanding their global footprint, the market is becoming more competitive, with increased availability of advanced devices, which benefits healthcare providers and patients through improved options and reduced costs.
The overall impact of these developments is a rapidly evolving market characterized by innovation, increased adoption, and expanded application areas. This growth is enhancing procedural safety, improving patient outcomes, and driving economic opportunities within the healthcare sector. As these trends continue, the percutaneous vessel closure device market is positioned for sustained expansion and technological leadership.
Strategic Growth Opportunities in the Percutaneous Vessel Closure Device Market
The percutaneous vessel closure device market is experiencing rapid growth driven by increasing minimally invasive procedures, technological advancements, and rising demand for faster patient recovery. As healthcare providers seek efficient solutions to reduce complications and improve outcomes, the market presents significant opportunities for innovation and expansion. Strategic investments and product development are crucial to capturing market share and addressing the evolving needs of hospitals, clinics, and surgical centers worldwide.
• Growing Adoption of Minimally Invasive Procedures: The increasing preference for minimally invasive surgeries across various medical fields is a key driver for percutaneous vessel closure devices. These devices enable quicker procedures, reduce patient discomfort, and lower complication rates. As hospitals aim to improve patient outcomes and operational efficiency, demand for reliable closure solutions is rising, creating substantial growth opportunities for manufacturers to develop advanced, user-friendly devices tailored to diverse clinical settings.
• Technological Innovations Enhancing Device Performance: Advances in materials, design, and deployment mechanisms are significantly improving the safety and efficacy of vessel closure devices. Innovations such as bio-absorbable materials and automated deployment systems are reducing risks like bleeding and vessel damage. Continuous R&D efforts are expected to lead to smarter, more precise devices, expanding their application scope and attracting new users, thereby fueling market growth and competitive differentiation.
• Increasing Prevalence of Cardiovascular Diseases: The global rise in cardiovascular conditions, including coronary artery disease and peripheral artery disease, is boosting the need for effective vascular access management. Percutaneous vessel closure devices are essential in procedures like angiography and stent placement. The growing patient population and expanding procedural volume are creating a sustained demand for reliable closure solutions, encouraging manufacturers to innovate and diversify their product offerings to meet clinical needs.
• Rising Healthcare Expenditure and Reimbursement Support: Increasing healthcare budgets and favorable reimbursement policies in many regions are facilitating the adoption of advanced medical devices, including vessel closure systems. Hospitals and clinics are more willing to invest in high-quality, efficient closure devices that can reduce procedure time and complications. This financial support encourages market players to expand their product lines and penetrate emerging markets, further accelerating market growth and accessibility.
• Strategic Collaborations and Market Expansion Initiatives: Partnerships between device manufacturers, healthcare providers, and research institutions are fostering innovation and expanding market reach. Collaborations facilitate the development of next-generation devices and enable entry into untapped markets. Additionally, geographic expansion into emerging economies with rising healthcare infrastructure is creating new revenue streams. These strategic initiatives are vital for sustaining growth, enhancing product portfolios, and establishing a competitive edge in the evolving market landscape.
In conclusion, these growth opportunities collectively are poised to significantly influence the expansion and innovation within the percutaneous vessel closure device market, driving improved clinical outcomes and broadening access to advanced vascular closure solutions worldwide.
Percutaneous Vessel Closure Device Market Driver and Challenges
The percutaneous vessel closure device market is influenced by a variety of technological, economic, and regulatory factors. Advances in minimally invasive procedures and the increasing prevalence of cardiovascular diseases are significant drivers. Additionally, regulatory approvals and reimbursement policies play crucial roles in shaping market growth. Economic factors such as healthcare expenditure and technological innovations further impact the adoption rate of these devices. However, the market also faces challenges, including regulatory hurdles, high device costs, and concerns over safety and efficacy. Understanding these drivers and challenges is essential for stakeholders aiming to capitalize on market opportunities and address potential barriers effectively.
The factors responsible for driving the percutaneous vessel closure device market include:
• Technological Advancements: The development of innovative closure devices with improved safety profiles, ease of use, and enhanced efficacy has significantly propelled market growth. New materials and design improvements reduce complication rates and procedural times, making procedures more efficient and safer for patients. These innovations attract healthcare providers to adopt newer devices, expanding market reach. Continuous R&D efforts are expected to further enhance device performance, fostering confidence among clinicians and patients alike. As technology evolves, the market is poised for sustained growth driven by these cutting-edge solutions.
• Rising Prevalence of Cardiovascular Diseases: The increasing incidence of cardiovascular conditions such as coronary artery disease, peripheral artery disease, and stroke has led to a higher demand for minimally invasive interventions. Percutaneous procedures are preferred due to their reduced recovery times and lower complication risks. This surge in cardiovascular cases directly correlates with increased adoption of vessel closure devices to ensure safe and effective closure post-procedure. The aging population and lifestyle-related risk factors further contribute to this trend, creating a robust demand for advanced closure devices across healthcare settings.
• Growing Adoption of Minimally Invasive Procedures: The shift from traditional open surgeries to minimally invasive techniques is a key driver. Percutaneous vessel closure devices facilitate quicker procedures, less pain, and shorter hospital stays, aligning with the healthcare industrys focus on patient-centric care. As hospitals and clinics increasingly adopt these techniques, the demand for reliable closure devices rises. This trend is supported by technological innovations and clinician training programs, which enhance procedural success rates. The convenience and safety offered by minimally invasive procedures are expected to sustain the markets upward trajectory.
• Favorable Regulatory Environment and Reimbursement Policies: Regulatory approvals from agencies such as the FDA and CE mark facilitate market entry and product acceptance. Additionally, reimbursement policies that cover minimally invasive procedures encourage healthcare providers to adopt vessel closure devices. These policies reduce financial barriers for patients and providers, promoting wider usage. Ongoing regulatory support and clear guidelines ensure device safety and efficacy, boosting clinician confidence. As regulatory frameworks become more streamlined, market players are motivated to innovate and expand their product portfolios, further accelerating market growth.
• Increasing Healthcare Expenditure and Technological Innovation: Rising healthcare spending worldwide enables hospitals and clinics to invest in advanced medical devices, including vessel closure systems. Technological innovations, such as bioresorbable materials and hybrid closure techniques, enhance device performance and safety. This financial and technological support fosters a competitive environment that drives product development and adoption. Moreover, increased investment in healthcare infrastructure and training programs ensures that clinicians are equipped to utilize these advanced devices effectively, contributing to overall market expansion.
The challenges facing this percutaneous vessel closure device market include:
• Stringent Regulatory Hurdles: Navigating complex regulatory pathways can delay product launches and increase costs for manufacturers. Regulatory agencies require extensive clinical data to demonstrate safety and efficacy, which can be time-consuming and expensive. Variations in approval processes across regions add to the complexity, potentially limiting market access. These hurdles can slow down innovation and reduce the pace of new product introduction, impacting overall market growth. Companies must invest heavily in compliance and clinical trials, which can be a significant barrier, especially for smaller players.
• High Device Costs and Reimbursement Limitations: The cost of advanced vessel closure devices can be prohibitive, especially in emerging markets. Limited reimbursement options further restrict adoption, as healthcare providers may be reluctant to invest in expensive devices without assured financial returns. This economic barrier hampers market penetration in cost-sensitive regions and among smaller healthcare facilities. Additionally, price competition may lead to compromises on device quality or innovation, affecting overall market quality and growth prospects.
• Safety and Efficacy Concerns: Despite technological advancements, safety issues such as device-related complications, bleeding, or vessel damage remain concerns. Clinicians may be hesitant to adopt new devices without extensive long-term data confirming safety and efficacy. Negative clinical outcomes can lead to reduced confidence and slower adoption rates. Addressing these concerns requires ongoing clinical research and post-market surveillance, which can be resource-intensive. Ensuring consistent device performance and safety is critical to overcoming these barriers and maintaining market growth.
In summary, the percutaneous vessel closure device market is driven by technological innovations, increasing cardiovascular disease prevalence, and supportive regulatory and economic factors. However, challenges such as regulatory complexities, high costs, and safety concerns pose significant hurdles. The interplay of these drivers and challenges will shape the markets future trajectory, requiring stakeholders to innovate, adapt, and collaborate to maximize opportunities while mitigating risks. Overall, the market is poised for growth, provided that these factors are managed effectively to ensure safe, affordable, and accessible solutions for patients worldwide.
List of Percutaneous Vessel Closure Device Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies percutaneous vessel closure device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the percutaneous vessel closure device companies profiled in this report include-
• Abbott
• Terumo
• Cardinal Health
• Haemonetics
• Merit Medical
• Grena
• Purple Surgical
• Frankman
• Pelter Medical
• Tianjin Rich
Percutaneous Vessel Closure Device Market by Segment
The study includes a forecast for the global percutaneous vessel closure device market by type, clinical procedure, access site type, application, and region.
Percutaneous Vessel Closure Device Market by Type [Value from 2019 to 2031]:
• Suture-based Closure Devices
• Collagen Plug-based Devices
• Clip-based Closure Systems
• Sealant-based Closure Devices
Percutaneous Vessel Closure Device Market by Clinical Procedure [Value from 2019 to 2031]:
• Interventional Cardiology
• Peripheral Vascular Interventions
• Structural Heart Procedures
• Neurovascular Procedures
Percutaneous Vessel Closure Device Market by Access Site Type [Value from 2019 to 2031]:
• Femoral Artery
• Femoral Vein
• Radial Artery
• Others
Percutaneous Vessel Closure Device Market by Application [Value from 2019 to 2031]:
• Hospitals
• ASCs
• Online
Percutaneous Vessel Closure Device Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Percutaneous Vessel Closure Device Market
The percutaneous vessel closure device market has experienced significant growth driven by advancements in minimally invasive procedures, increasing adoption in cardiovascular interventions, and technological innovations. As healthcare systems evolve, countries are focusing on improving procedural safety, reducing recovery times, and expanding the use of these devices across various medical settings. Regulatory approvals and rising healthcare expenditure further propel market expansion. The following summaries highlight recent developments in the United States, China, Germany, India, and Japan, reflecting regional trends and innovations shaping the global landscape.
• United States: The US market has seen rapid adoption of advanced closure devices, driven by a rise in minimally invasive cardiac procedures and favorable reimbursement policies. Key players are launching next-generation devices with enhanced safety features, and there is increased focus on reducing complication rates. Regulatory bodies like the FDA are approving innovative products, boosting market growth. Hospitals are investing in training programs to improve procedural outcomes, and the adoption of hybrid procedures is expanding the device application scope.
• China: China’s market is experiencing rapid growth due to the increasing prevalence of cardiovascular diseases and expanding healthcare infrastructure. Local manufacturers are developing cost-effective closure devices to meet rising demand, while international companies are entering the market through strategic partnerships. Government initiatives to improve healthcare access and technological adoption are accelerating market penetration. Additionally, the adoption of minimally invasive techniques is increasing, supported by rising awareness among healthcare professionals.
• Germany: The German market is characterized by high adoption of advanced closure devices, driven by a well-established healthcare system and stringent regulatory standards. Innovations focus on improving device safety, reducing procedure time, and minimizing complications. The country’s emphasis on research and development fosters the introduction of novel products. Moreover, Germany’s aging population contributes to increased demand for minimally invasive cardiovascular procedures, further fueling market growth.
• India: India’s market is witnessing rapid expansion due to a large patient population with cardiovascular conditions and increasing healthcare expenditure. Local manufacturers are offering affordable, high-quality closure devices, while international companies are expanding their presence. The government’s focus on improving healthcare infrastructure and increasing procedural volumes in urban and rural areas is boosting market growth. Training programs and awareness campaigns are also promoting the adoption of percutaneous closure devices across the country.
• Japan: Japan’s market is driven by an aging population and a high prevalence of cardiovascular diseases. The country emphasizes technological innovation, with companies developing devices that offer enhanced safety and ease of use. Regulatory approvals are streamlined, facilitating faster market entry for new products. Japan’s focus on minimally invasive procedures and outpatient treatments is expanding the utilization of vessel closure devices. Additionally, collaborations between industry and academia are fostering research and development in this sector.
Features of the Global Percutaneous Vessel Closure Device Market
Market Size Estimates: Percutaneous vessel closure device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Percutaneous vessel closure device market size by various segments, such as by type, clinical procedure, access site type, application, and region in terms of value ($B).
Regional Analysis: Percutaneous vessel closure device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, clinical procedures, access site types, applications, and regions for the percutaneous vessel closure device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the percutaneous vessel closure device market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for percutaneous vessel closure device market?
Answer: The global percutaneous vessel closure device market is expected to grow with a CAGR of 6.8% from 2025 to 2031.
Q2. What are the major drivers influencing the growth of the percutaneous vessel closure device market?
Answer: The major drivers for this market are the increasing demand for minimally invasive procedures, the rising prevalence of cardiovascular diseases, and the growing adoption in interventional cardiology.
Q3. What are the major segments for percutaneous vessel closure device market?
Answer: The future of the percutaneous vessel closure device market looks promising with opportunities in the hospital, ASC, and online markets.
Q4. Who are the key percutaneous vessel closure device market companies?
Answer: Some of the key percutaneous vessel closure device companies are as follows:
• Abbott
• Terumo
• Cardinal Health
• Haemonetics
• Merit Medical
• Grena
• Purple Surgical
• Frankman
• Pelter Medical
• Tianjin Rich
Q5. Which percutaneous vessel closure device market segment will be the largest in future?
Answer: Lucintel forecasts that, within the type category, suture-based closure device is expected to witness higher growth over the forecast period.
Q6. In percutaneous vessel closure device market, which region is expected to be the largest in next 5 years?
Answer: In terms of region, APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the percutaneous vessel closure device market by type (suture-based closure devices, collagen plug-based devices, clip-based closure systems, and sealant-based closure devices), clinical procedure (interventional cardiology, peripheral vascular interventions, structural heart procedures, and neurovascular procedures), access site type (femoral artery, femoral vein, radial artery, and others), application (hospitals, ASCs, and online), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 6 years and what has its impact been on the industry?
For any questions related to Percutaneous Vessel Closure Device Market, Percutaneous Vessel Closure Device Market Size, Percutaneous Vessel Closure Device Market Growth, Percutaneous Vessel Closure Device Market Analysis, Percutaneous Vessel Closure Device Market Report, Percutaneous Vessel Closure Device Market Share, Percutaneous Vessel Closure Device Market Trends, Percutaneous Vessel Closure Device Market Forecast, Percutaneous Vessel Closure Device Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.